Research
Micronutrients & recovery
Marine n-3 fatty acid supplementation (specifically EPA at 4g/day) reduces cardiovascular events in high-risk patients with elevated triglycerides, independent of statin therapy.
If you have high triglycerides and are at high cardiovascular risk, ask your doctor about high-dose EPA (4g/day). This specific intervention has been shown to significantly reduce heart attacks and strokes, even for those already taking statins.
StrongSupportsHIGH confidence
In REDUCE-IT, treatment of patients at elevated cardiovascular risk... with 4 g of EPA/day resulted in a 25% relative risk reduction... of the primary composite end point... It is noteworthy that these results were achieved on top of statin therapy, suggesting additive value of EPA.
Why this rating
Based on the REDUCE-IT trial, a large, landmark clinical trial.
Source
Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors
Katharina Lechner et al. · European Journal of Preventive Cardiology · 2019
DOI 10.1177/2047487319869400
narrative_reviewCited 360×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Adherence to low-risk lifestyle factors (whole food/Mediterranean diet, physical activity, stress management, sleep) shifts tissue cross-talk from a proinflammatory to an anti-atherogenic milieu, reducing cardiovascular risk independently of conventional risk factor changes.Good
- Nutritional ketosis, induced by carbohydrate restriction or caloric restriction, reduces systemic inflammation and ASCVD risk markers primarily through the ketone body beta-hydroxybutyrate (BHB) inhibiting the NLRP3 inflammasome.Good
- Physical activity and cardiorespiratory fitness neutralize the adverse effects of adiposity and traditional risk factors, acting as independent therapeutic targets for ASCVD prevention.Good
Related findings · Micronutrients & recovery
- Trans fats (industrial trans-fatty acids) are unequivocally harmful and should be completely avoided as they raise LDL-C, TGs, and Apo B while lowering HDL-C.Strong
- For menopausal women with osteoporosis, first-line pharmacologic therapies include alendronate, risedronate, zoledronic acid, and denosumab for the prevention of hip, nonvertebral, and vertebral fractures.Strong
- Folic acid fortification of flour prevents neural tube birth defects, and mandatory fortification is more effective than voluntary supplementation alone.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →